How is a Monospot (Mononucleosis spot test) performed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Perform a Monospot Test

The Monospot test is a rapid heterophile antibody test performed on a serum or plasma sample using red cell or latex agglutination to detect antired cell antibodies produced during EBV infection. 1

Specimen Collection and Handling

  • Collect a serum specimen as soon as possible after symptom onset for optimal diagnostic accuracy. 2
  • The test can be performed on either serum or plasma samples obtained through standard venipuncture. 1
  • If the initial Monospot test is negative but clinical suspicion remains high, the test can be repeated on a serum specimen obtained 7-10 days later, at which time the heterophile antibodies are more likely to be positive if EBV infection is present. 3

Test Methodology

  • The Monospot test uses red cell or latex agglutination assays that detect heterophile antibodies (antired cell antibodies) produced as part of the polyclonal antibody response during EBV infection. 1
  • The test is rapid, inexpensive, and can be performed from the onset of symptoms of infectious mononucleosis. 1
  • Results are typically available within minutes, making it an efficient point-of-care diagnostic tool. 4

Test Performance Characteristics

  • In adolescents and young adults (15-24 years), the Monospot test has 87% sensitivity and 91% specificity for diagnosing acute EBV infection. 4
  • The test has high specificity and sensitivity in adolescents but performs poorly in children under 4 years of age, where it has low sensitivity and low negative predictive value. 1
  • False-negative results occur in approximately 10% of cases, most commonly in younger children and during the first week of illness in adults. 3, 5

Critical Interpretation Points

  • A positive Monospot test is considered diagnostic for EBV infection and no further EBV-specific testing is required. 3, 5
  • A negative Monospot test does not rule out EBV infection, particularly in children under 10 years or during the first week of symptoms. 3, 5
  • When the Monospot is negative but clinical suspicion remains high (fever, pharyngitis, posterior cervical lymphadenopathy, atypical lymphocytosis >10%), perform EBV-specific serologic testing for VCA IgM, VCA IgG, and EBNA antibodies on the same sample. 3, 5, 2

Common Pitfalls to Avoid

  • Do not rely solely on a negative Monospot test to exclude infectious mononucleosis, especially in children, as this leads to misdiagnosis. 5
  • The test should not be used as the primary diagnostic tool in children under 4 years of age; proceed directly to EBV-specific serology in this population. 1
  • False-positive results may occur in patients with leukemia, pancreatic carcinoma, viral hepatitis, CMV infection, other viral infections, autoimmune disease, and hematological malignancies. 5, 1
  • Heterophile antibodies may take time to develop, so timing matters—testing too early in the illness course increases the risk of false-negative results. 5, 4

Supporting Laboratory Findings

  • Obtain a complete blood count with differential to assess for >40% lymphocytes and >10% atypical lymphocytes, which supports the diagnosis when present. 4
  • The presence of elevated liver enzymes increases clinical suspicion for infectious mononucleosis even when the heterophile antibody test is negative. 4

References

Research

How to use … the Monospot and other heterophile antibody tests.

Archives of disease in childhood. Education and practice edition, 2017

Guideline

EBV Testing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Infectious Mononucleosis: Rapid Evidence Review.

American family physician, 2023

Guideline

Diagnostic Approach to Infectious Mononucleosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the most appropriate medication for an 18-year-old woman with infectious mononucleosis (positive heterophile antibody test), fever, sore throat, and swollen cervical lymph nodes, who has a history of Attention Deficit Hyperactivity Disorder (ADHD) managed with amphetamine (amphetamine) dextroamphetamine and seasonal allergies?
What is the recommended diagnostic and treatment approach for a 9-year-old suspected of having infectious mononucleosis (mono)?
What is the best medication for a patient with fever, tachycardia (heart rate 110 beats per minute), tachypnea (respirations 21 per minute), petite eye, palatal enlargement, tonsillar enlargement, and anterior cervical lymphadenopathy, with a peripheral blood smear showing 12% atypical lymphocytes?
What is the next step in evaluating a 15-year-old male with splenomegaly (enlarged spleen) and negative mononucleosis (mono) testing?
Can a person contract infectious mononucleosis (mono) twice?
What are the treatment options for rheumatological emergencies, such as severe flare-ups of rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE)?
What are the management options for Polycystic Ovary Disorder (PCOD)?
What is the management approach for shock in the context of Systemic Inflammatory Response Syndrome (SIRS)?
What is the first line of treatment for patients presenting with Small Intestine Bacterial Overgrowth (SIBO) symptoms?
Does extramammary Paget's disease (EMPD) show Fluorodeoxyglucose (FDG) uptake in Positron Emission Tomography (PET) Computed Tomography (CT) scans?
What is the most common site for aspiration pneumonia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.